Clinical Application of Polygenic Risk Score in IgA Nephropathy

Overview

Journal Phenomics

Publisher Springer

Date 2024 Jun 17

PMID 38884057

Authors

Linlin Xu

Ting Gan

Pei Chen

Yang Liu

Shu Qu

Sufang Shi

Lijun Liu

Xujie Zhou

Jicheng Lv

Hong Zhang

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s43657-023-00138-6.

Citing Articles

Towards Risk Stratification in Clinical Care for IgA Nephropathy: Genetic Risk Scores: Comments on the Study "Clinical Application of Polygenic Risk Score in IgA Nephropathy".

Berthier C, Ju W Phenomics. 2024; 4(5):527-530.

PMID: 39723228 PMC: 11666848. DOI: 10.1007/s43657-024-00184-8.

References

Lai K, Tang S, Schena F, Novak J, Tomino Y, Fogo A . IgA nephropathy. Nat Rev Dis Primers. 2016; 2:16001. DOI: 10.1038/nrdp.2016.1. View

Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F . Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012; 8(6):e1002765. PMC: 3380840. DOI: 10.1371/journal.pgen.1002765. View

Kiryluk K, Sanchez-Rodriguez E, Zhou X, Zanoni F, Liu L, Mladkova N . Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat Genet. 2023; 55(7):1091-1105. PMC: 11824687. DOI: 10.1038/s41588-023-01422-x. View

Willer C, Li Y, Abecasis G . METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010; 26(17):2190-1. PMC: 2922887. DOI: 10.1093/bioinformatics/btq340. View

Robson M, Reiner A, Brooks J, Concannon P, John E, Mellemkjaer L . Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study. J Natl Cancer Inst. 2017; 109(10). PMC: 5939625. DOI: 10.1093/jnci/djx051. View

Liu G, Peng J, Liao Z, Locascio J, Corvol J, Zhu F . Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Nat Genet. 2021; 53(6):787-793. PMC: 8459648. DOI: 10.1038/s41588-021-00847-6. View

Kiryluk K, Moldoveanu Z, Sanders J, Eison T, Suzuki H, Julian B . Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int. 2011; 80(1):79-87. PMC: 3641561. DOI: 10.1038/ki.2011.16. View

Toulopoulou T, Zhang X, Cherny S, Dickinson D, Berman K, Straub R . Polygenic risk score increases schizophrenia liability through cognition-relevant pathways. Brain. 2018; 142(2):471-485. PMC: 6359897. DOI: 10.1093/brain/awy279. View

Zhou X, Qi Y, Hou P, Lv J, Shi S, Liu L . Cumulative effects of variants identified by genome-wide association studies in IgA nephropathy. Sci Rep. 2014; 4:4904. PMC: 4014895. DOI: 10.1038/srep04904. View

10.

Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M . Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014; 46(11):1187-96. PMC: 4213311. DOI: 10.1038/ng.3118. View

11.

Roberts I, Cook H, Troyanov S, Alpers C, Amore A, Barratt J . The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009; 76(5):546-56. DOI: 10.1038/ki.2009.168. View

12.

Li M, Foo J, Wang J, Low H, Tang X, Toh K . Identification of new susceptibility loci for IgA nephropathy in Han Chinese. Nat Commun. 2015; 6:7270. PMC: 4458882. DOI: 10.1038/ncomms8270. View

13.

Choi S, OReilly P . PRSice-2: Polygenic Risk Score software for biobank-scale data. Gigascience. 2019; 8(7). PMC: 6629542. DOI: 10.1093/gigascience/giz082. View

14.

Barsoum R . Glomerulonephritis in disadvantaged populations. Clin Nephrol. 2010; 74 Suppl 1:S44-50. DOI: 10.5414/cnp74s044. View

15.

Li M, Wang L, Shi D, Foo J, Zhong Z, Khor C . Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy. J Am Soc Nephrol. 2020; 31(12):2949-2963. PMC: 7790208. DOI: 10.1681/ASN.2019080799. View

16.

Mizerska-Wasiak M . How to take advantage of easily available biomarkers in patients with IgA nephropathy: IgA and C3 in serum and kidney biopsies. Pediatr Nephrol. 2022; 38(5):1439-1448. DOI: 10.1007/s00467-022-05644-9. View

17.

Wakai K, Nakai S, Matsuo S, Kawamura T, Hotta N, Maeda K . Risk factors for IgA nephropathy: a case-control study with incident cases in Japan. Nephron. 2001; 90(1):16-23. DOI: 10.1159/000046309. View

18.

Zhang X, Rice M, Tworoger S, Rosner B, Eliassen A, Tamimi R . Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study. PLoS Med. 2018; 15(9):e1002644. PMC: 6122802. DOI: 10.1371/journal.pmed.1002644. View

19.

Northcutt M, Shi Z, Zijlstra M, Shah A, Zheng S, Yen E . Polygenic risk score is a predictor of adenomatous polyps at screening colonoscopy. BMC Gastroenterol. 2021; 21(1):65. PMC: 7881602. DOI: 10.1186/s12876-021-01645-4. View

20.

Wyatt R, Rivas M, Julian B, Quiggins P, Woodford S, McMorrow R . Regionalization in hereditary IgA nephropathy. Am J Hum Genet. 1987; 41(1):36-50. PMC: 1684172. View